For this global initiative to advance early cancer detection technologies, increasing treatment options and survival rates Inspire2Live started a social enterprise called OncoInv. Our partner in this is the Chinese/American company SeekIn. Through SeekIn we make our dream a reality and hope is on the horizon because their products for detecting cancer at a very early stage are already available. The founder and CEO of SeekIn, Mao Mao, is one of our advocates and, together with him and his team in Shenzhen, China, Inspire2Live is bringing early detection products to low- and middle-income countries. High-income countries will also have access however the most important driver for everyone involved is that these products become available for all.
The first implementation of the product(s) started in 2023. It is used already in Bulgaria, Brazil, China, Costa Rica, Mexico, Nigeria and Poland. Confirmative trials are being set up in Ghana, India and Kenya. We’re in discussion with Colombia, Dubai, Guinee, Pakistan, Senegal to introduce early detection. Many more will follow.
